InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Prelack Steven, Director. Director active across 1 company, notably Aerpio Pharmaceuticals, Inc.. Aggregated, 2 reports have been recorded. History available since 30 June 2021. The latest transaction was filed on 30 June 2021 (Attribution). Regulator: SEC (Form 4). The full history is free.
2 of 2 declarations
Prelack Steven is a Board Member at Aerpio Pharmaceuticals, Inc. He participates in the governance of the company and strategic decision-making, contributing to its development in the pharmaceutical sector.